Parkinsonโs Disease Lawsuit Claims Dow and Corteva Sold Dangerous Chlorpyrifos Despite Safer Alternatives
Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Gabapentin Dementia Lawsuit Gabapentin dementia lawsuits are being investigated against Pfizer and other drug manufacturers following studies linking the widely prescribed medication to an increased risk of dementia, Alzheimer's disease and mild cognitive impairment. Learn about the allegations, recent research, lawsuit updates and potential settlement compensation.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Drug Makers Abusing Law Meant To Help Meds Designed To Treat Rare Diseases: Johns Hopkins December 4, 2015 Irvin Jackson Add Your CommentsResearchers from Johns Hopkins indicate that drug manufacturers are abusing a law designed to get unprofitable medications that treat rare diseases onto the market, with seven of the top ten best selling drugs in the world approved through the law.ย A report published last month in the American Journal of Clinical Oncology finds that pharmaceutical companies are “gaming the system” in regards to the Orphan Drug Act, which is meant to be used to fast-track the approval of drugs designed to treat deadly conditions that only impact a limited population. Instead, Johns Hopkins researchers warn that the law is being used to approve mainstream blockbuster drugs that are then promoted and prescribed for uses never approved by the FDA.Researchers say that in 2014, 41% of new drugs approved by the FDA were introduced via the Orphan drug law. Many of these drugs move on to become blockbusters, with more than $1 billion in sales. However, the law, originally approved in 1983, was meant to help drug manufacturers introduce medications that would otherwise be unprofitable, granting special patent protections and a faster route to the market, in situations where they would help 200,000 patients or less.Do You Know about…Spinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONDo You Know AboutโฆSpinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONThe law grants the drug seven years market exclusivity, tax breaks in the millions, and waives the millions of dollars of marketing application fees.Some of the now blockbuster drugs that were approved through the Orphan Act include Humira, Rituxan, Avastin, Herceptin, Remicade, Revlimid and Crestor, which, despite huge sales, received a new orphan designation in 2014, that extended its patent for an additional six months, preventing generic competition, according to the report.“The industry has been gaming the system by slicing and dicing indications so that drugs qualify for lucrative orphan status benefits,” said Dr. Martin Makary, professor of surgery at Johns Hopkins, in a press release. “As a result, funding support intended for rare disease medicine is diverted to fund the development of blockbuster drugs.”According to the report, these drugs are either illegally promoted off-label by drug manufacturers, or they quickly move to receive broader FDA drug use approvals once they’ve received Orphan Act benefits.One of the examples cited is Rituxamab, sold under the brand names Rituxan, MabThera and Zytux. The drug was originally approved for the treatment of follicular B-cell non-Hodgkin’s lymphoma, which is suffered by only about 14,000 patients a year. The drug is now approved to treat a number of other ailments, including rheumatoid arthritis, to treat some forms of cancer, and to prevent organ rejection after kidney transplant. In 2014, the drug brought in $3.7 billion in sales.In fact, 18 of the 41 drugs approved by the FDA were done under Orphan status, and are expected to generate $107 billion in sales this year.Researchers estimated that by 2020, the drug industry will be bringing in $176 billion through drugs approved by an act designed to help drugs expected to see little profitability.“This is a financially toxic practice that is also unethical,” study co-author Michael Daniel, a research fellow in the Department of Surgery at Johns Hopkins, said in the press release. “It’s time to ensure that we also render it illegal.”Daniel said that the practice inflates drug prices, and the additional health care costs are passed on to consumers through higher health insurance costs.The researchers recommend that to fix the problem, the regulations be changed so that once a drug exceeds the 200,000 population benchmark meant for Orphan drug status, it loses the benefits of the act. Written by: Irvin JacksonSenior Legal Journalist & Contributing EditorIrvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Avastin, Crestor, Herceptin, Humira, Remicade, Revlimid, RituxanMore Lawsuit Stories Parkinsonโs Disease Lawsuit Claims Dow and Corteva Sold Dangerous Chlorpyrifos Despite Safer Alternatives November 19, 2026 Amazon Fire Bowl Lawsuit Filed After 9-Year-Old Girl Suffers Catastrophic Burns November 19, 2026 Kratom Ban Upheld in Massachusetts as Judge Cites Addiction and Fatal Overdose Risks November 19, 2026 0 Comments PhoneThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Parkinsonโs Disease Lawsuit Claims Dow and Corteva Sold Dangerous Chlorpyrifos Despite Safer Alternatives (Posted: today)A California man’s chlorpyrifos lawsuit blames years of exposure to the pesticide for the development of Parkinson’s disease that forced him out of his profession.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITPesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (11/13/2026)Chlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinsonโs Disease (10/01/2026) Gabapentin Lawsuit Alleges Nerve Pain Drug Caused Severe Headaches, Memory Loss (Posted: yesterday)A Washington womanโs lawsuit claims she suffered persistent neurological problems after using gabapentin for fibromyalgia.MORE ABOUT: GABAPENTIN DEMENTIA LAWSUITNeurontin Dementia Lawsuit Alleges Gabapentin Caused Early-Onset Memory Loss (11/10/2026)Gabapentin Dementia Risks May Result in Lawsuits Against Drug Maker (09/17/2026) DraftKings Class Action Lawsuit Alleges Sports Betting Odds Changes Misled Consumers (Posted: 2 days ago)A class action lawsuit alleges DraftKings makes changes to its wagering format that are intentionally designed to trick consumers into placing bets they did not intend to make.MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITOnline Gambling Class Action Claims Betsperts Used Aggressive Marketing Tactics to Keep Players Spending (11/13/2026)DraftKings, FanDuel Face Questions From Lawmakers Over VIP Rewards Targeting Problem Gamblers (11/02/2026)DraftKings Gambling Lawsuit Alleges Illegal Scheme Fueled Addiction (10/27/2026)
Parkinsonโs Disease Lawsuit Claims Dow and Corteva Sold Dangerous Chlorpyrifos Despite Safer Alternatives November 19, 2026
Kratom Ban Upheld in Massachusetts as Judge Cites Addiction and Fatal Overdose Risks November 19, 2026
Parkinsonโs Disease Lawsuit Claims Dow and Corteva Sold Dangerous Chlorpyrifos Despite Safer Alternatives (Posted: today)A California man’s chlorpyrifos lawsuit blames years of exposure to the pesticide for the development of Parkinson’s disease that forced him out of his profession.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITPesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (11/13/2026)Chlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinsonโs Disease (10/01/2026)
Gabapentin Lawsuit Alleges Nerve Pain Drug Caused Severe Headaches, Memory Loss (Posted: yesterday)A Washington womanโs lawsuit claims she suffered persistent neurological problems after using gabapentin for fibromyalgia.MORE ABOUT: GABAPENTIN DEMENTIA LAWSUITNeurontin Dementia Lawsuit Alleges Gabapentin Caused Early-Onset Memory Loss (11/10/2026)Gabapentin Dementia Risks May Result in Lawsuits Against Drug Maker (09/17/2026)
DraftKings Class Action Lawsuit Alleges Sports Betting Odds Changes Misled Consumers (Posted: 2 days ago)A class action lawsuit alleges DraftKings makes changes to its wagering format that are intentionally designed to trick consumers into placing bets they did not intend to make.MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITOnline Gambling Class Action Claims Betsperts Used Aggressive Marketing Tactics to Keep Players Spending (11/13/2026)DraftKings, FanDuel Face Questions From Lawmakers Over VIP Rewards Targeting Problem Gamblers (11/02/2026)DraftKings Gambling Lawsuit Alleges Illegal Scheme Fueled Addiction (10/27/2026)